SMTL ID : 6mvo.1 (1 other biounit)

HCV NS5B 1A Y316 bound to Compound 49

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: R.505, V.530, R.531, T.532 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.531, A:T.532, A:T.532 Salt bridges: A:R.505 SO4.2: 5 residues within 4Å: Chain A: R.48, K.51, T.221, R.222, C.223 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:C.223 Water bridges: A:F.224, A:F.224 Salt bridges: A:R.48, A:K.51 SO4.3: 2 residues within 4Å: Chain A: G.516, R.517 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.517 Water bridges: A:G.515, A:A.518 Salt bridges: A:R.517

1 x K4P: 6-[(7-chloro-1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)(methylsulfonyl)amino]-5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide(Non-covalent)

K4P.4: 16 residues within 4Å: Chain A: P.197, R.200, L.204, L.314, Y.316, D.319, V.321, I.363, S.365, C.366, S.368, L.384, R.386, M.414, F.415, Y.448 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.204, A:L.204, A:Y.316, A:Y.316, A:V.321, A:L.384, A:M.414, A:F.415, A:F.415, A:Y.448 Hydrogen bonds: A:R.200, A:S.365, A:S.365, A:R.386, A:Y.448 Water bridges: A:R.200

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chong, P.Y. et al., Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. J.Med.Chem. (2019)

Release Date

2019-09-04

Peptides

RNA-directed RNA polymerase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RNA-directed RNA polymerase

Related Entries With Identical Sequence